LINZESSÂ® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children less than 18 years of age.
The Baylor Plan is developed by Baylor administrators during the Great Depression to help area citizens afford hospital care. It is the first prepaid hospital insurance plan in the United States and predecessor of Blue Cross.
Baylor Scott & White Quality Alliance Improves Care for Patients. BSWQA is developing a clinically integrated organization of physicians, hospitals, and other providers of care to improve quality and reduce overall costs of care. Real innovation is right here at Baylor Scott & White Research Institute. Positive change and evolution were recurring themes during 2014-15.